Literature DB >> 18721513

Changing trends of hospital utilization in patients after their first episode of atrial fibrillation.

Yoko Miyasaka1, Marion E Barnes, Bernard J Gersh, Stephen S Cha, Kent R Bailey, James B Seward, Teresa S M Tsang.   

Abstract

A marked increase in hospitalization for patients with atrial fibrillation (AF) has previously been noted. Whether this increase is related to a change in the prevalence of AF or a change in the pattern of practice with respect to the management of AF remains unclear. To determine the trends in hospital utilization after first AF in a community-based setting (Olmsted County, Minnesota), residents diagnosed with first AF from 1980 to 2000 were identified and followed until 2004. The primary outcome of interest was hospital admission for cardiovascular reasons. Of a total of 4,498 subjects (73 +/- 14 years old, 51% men), 2,503 (56%) were admitted to the hospital for cardiovascular causes >or=1 time during a mean follow-up of 5.5 +/- 5.0 years. Risk of first hospitalization was greatest during the first year of AF (cumulative incidence 31%, 95% confidence interval [CI] 30 to 32). First hospitalization was strongly related to age (p <0.0001) but not to sex (p = 0.38). From 1980 to 2000, the age-and sex-adjusted rate of first hospitalization increased, on average, by 2.5% a year (95% CI 1.8 to 3.2, p <0.0001), even after multivariable adjustment for co-morbidities. When we excluded all hospital admissions for the purposes of AF management, the increase in hospitalization was only 0.8% per year (95% CI 0.05 to 1.6, p = 0.04), which was no longer significant after multivariable adjustment for co-morbidities (p = 0.25). In conclusion, the marked increase in hospitalization after first AF diagnosis from 1980 to 2000 appeared to be largely driven by the changing practice pattern in AF management.

Entities:  

Mesh:

Year:  2008        PMID: 18721513      PMCID: PMC3743254          DOI: 10.1016/j.amjcard.2008.04.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

Review 1.  International consensus on nomenclature and classification of atrial fibrillation; a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors:  S Lévy; A J Camm; S Saksena; E Aliot; G Breithardt; H Crijns; W Davies; N Kay; E Prystowsky; R Sutton; A Waldo; D G Wyse
Journal:  Europace       Date:  2003-04       Impact factor: 5.214

2.  Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter Abhayaratna; James B Seward; Toshiji Iwasaka; Teresa S M Tsang
Journal:  Eur Heart J       Date:  2006-01-06       Impact factor: 29.983

3.  The natural history of congestive heart failure: the Framingham study.

Authors:  P A McKee; W P Castelli; P M McNamara; W B Kannel
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

4.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

5.  Time trends of ischemic stroke incidence and mortality in patients diagnosed with first atrial fibrillation in 1980 to 2000: report of a community-based study.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; James B Seward; Kent R Bailey; Toshiji Iwasaka; Teresa S M Tsang
Journal:  Stroke       Date:  2005-10-13       Impact factor: 7.914

6.  Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986--1996.

Authors:  S Stewart; K MacIntyre; M M MacLeod; A E Bailey; S Capewell; J J McMurray
Journal:  Eur Heart J       Date:  2001-04       Impact factor: 29.983

7.  Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001.

Authors:  Farhat Khairallah; Rana Ezzedine; Leonard I Ganz; Barry London; Samir Saba
Journal:  Am J Cardiol       Date:  2004-08-15       Impact factor: 2.778

8.  Rising rates of hospital admissions for atrial fibrillation.

Authors:  Jens Friberg; Pernille Buch; Henrik Scharling; Niels Gadsbphioll; Gorm B Jensen
Journal:  Epidemiology       Date:  2003-11       Impact factor: 4.822

9.  Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.

Authors:  Wendy A Wattigney; George A Mensah; Janet B Croft
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

10.  Population rates of hospitalization for atrial fibrillation/flutter in Canada.

Authors:  Karin H Humphries; Cynthia Jackevicius; Yanyan Gong; Larry Svensen; Jafna Cox; Jack V Tu; Andreas Laupacis
Journal:  Can J Cardiol       Date:  2004-07       Impact factor: 5.223

View more
  19 in total

1.  A clinical prediction model to estimate risk for 30-day adverse events in emergency department patients with symptomatic atrial fibrillation.

Authors:  Tyler W Barrett; Amy R Martin; Alan B Storrow; Cathy A Jenkins; Frank E Harrell; Stephan Russ; Dan M Roden; Dawood Darbar
Journal:  Ann Emerg Med       Date:  2010-08-21       Impact factor: 5.721

2.  Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.

Authors:  Nancy M Allen LaPointe; David Dai; Laine Thomas; Jonathan P Piccini; Eric D Peterson; Sana M Al-Khatib
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-03-31

3.  Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.

Authors:  Sanjeev Saksena; April Slee; Albert L Waldo; Nick Freemantle; Mathew Reynolds; Yves Rosenberg; Snehal Rathod; Shannon Grant; Elizabeth Thomas; D George Wyse
Journal:  J Am Coll Cardiol       Date:  2011-11-01       Impact factor: 24.094

Review 4.  Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making?

Authors:  Michiel Rienstra; David D McManus; Emelia J Benjamin
Journal:  Circulation       Date:  2012-05-22       Impact factor: 29.690

Review 5.  Outcome of Patients Discharged after their First Detected Episode of Atrial Fibrillation.

Authors:  Sophie Gomes Md; Laure Champ-Rigot Md; Anthony Foucault Md; Pellissier Md Arnaud; Alain Lebon Md; Patrice Scanu Md; Paul Milliez Md PhD
Journal:  J Atr Fibrillation       Date:  2012-04-14

6.  Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States.

Authors:  Gerald V Naccarelli; Stephen S Johnston; Jay Lin; Parag P Patel; Kathy L Schulman
Journal:  Clin Cardiol       Date:  2010-05       Impact factor: 2.882

Review 7.  Cost effectiveness of antiarrhythmic medications in patients suffering from atrial fibrillation.

Authors:  Bernd Brüggenjürgen; Stefan Kohler; Nadja Ezzat; Thomas Reinhold; Stefan N Willich
Journal:  Pharmacoeconomics       Date:  2013-03       Impact factor: 4.981

8.  The Connection between Cardiac and Mental Disorder: Atrial Fibrillation in Patients with Psychiatric Disorder.

Authors:  Fa-Po Chung; Yenn-Jiang Lin
Journal:  Acta Cardiol Sin       Date:  2014-01       Impact factor: 2.672

Review 9.  Efficacy And Safety of Dabigatran Etexilate Utilization With Concomitant Dual Antiplatelet Therapy In Atrial Fibrillation.

Authors:  Osmar Antonio Centurión Md PhD Facc
Journal:  J Atr Fibrillation       Date:  2014-02-28

10.  Predictors of regional variations in hospitalizations following emergency department visits for atrial fibrillation.

Authors:  Tyler W Barrett; Wesley H Self; Cathy A Jenkins; Alan B Storrow; Benjamin S Heavrin; Candace D McNaughton; Sean P Collins; Jeffrey J Goldberger
Journal:  Am J Cardiol       Date:  2013-08-22       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.